key: cord-0835959-50iju57j
authors: Bost, Pierre; Giladi, Amir; Liu, Yang; Bendjelal, Yanis; Xu, Gang; David, Eyal; Blecher-Gonen, Ronnie; Cohen, Merav; Medaglia, Chiara; Li, Hanjie; Deczkowska, Aleksandra; Zhang, Shuye; Schwikowski, Benno; Zhang, Zheng; Amit, Ido
title: Host-viral infection maps reveal signatures of severe COVID-19 patients
date: 2020-05-08
journal: Cell
DOI: 10.1016/j.cell.2020.05.006
sha: 42062b7298efe0a9a4e5ce471bd6c8d7131d6cda
doc_id: 835959
cord_uid: 50iju57j

Viruses are a constant threat to global health as highlighted by the current COVID-19 pandemic. Currently, lack of data underlying how the human host interacts with viruses, including the SARS-CoV-2 virus, limits effective therapeutic intervention. We introduce Viral-Track, a computational method that globally scans unmapped scRNA-seq data for the presence of viral RNA, enabling transcriptional cell sorting of infected versus bystander cells. We demonstrate the sensitivity and specificity of Viral-Track to systematically detect viruses from multiple models of infection, including hepatitis B virus in an unsupervised manner. Applying Viral-Track to Bronchoalveloar-Lavage samples from severe and mild COVID-19 patients reveals a dramatic impact of the virus on the immune system of severe patients compared to mild cases. Viral-Track detects an unexpected co-infection of the human MetaPneumoVirus, present mainly in monocytes perturbed in type-I IFN-signaling. Viral-Track provides a robust technology for dissecting the mechanisms of viral-infection and pathology.

The development of efficient vaccines against viral pathogens is considered one of the biggest achievements of modern medicine, and significantly contributed to the increase in life expectancy worldwide. However, no vaccines exist for many life-threatening viruses such as HIV (Burton, 2019) , Zika virus (Pierson and Diamond, 2018) , or HCV (Bailey et al., 2019) . Additionally, efficient broad-spectrum antiviral drugs are still missing, making infectious diseases a significant challenge for modern health systems. Viruses can also trigger or fuel non-infectious diseases such as cancer (Young and Rickinson, 2004) and are suspected to contribute to various other chronic diseases such as Alzheimer disease (Itzhaki, 2018) , and various auto-immune disorders (Münz et al., 2009 ). The recent emergence of highly-pathogenic viruses such as the Ebola virus and the emerging SARS-CoV-2 pandemic recalls the constant threat that viruses represent to global health. So far, the SARS-CoV-2 pandemic has caused a global financial and social catastrophe, and is expected to make a significant long-lasting impact on human health (Zhu et al., 2020) . Despite intensive research efforts, little is known thus far regarding the interaction of the SARS-CoV-2 virus with the human host and, as a consequence, no efficient treatment has been designed so far (CHEN Jun, 2020) . Moreover, only few therapeutic targets have been identified, highlighting the urgency to develop additional strategies to dissect the virus-host interactions.

Single cell-RNA sequencing (scRNA-seq) is an emerging technology that has been extensively used to study several complex diseases, including cancer , neurodegeneration (Keren-Shaul et al., 2017) , auto-immune (Zhang et al., 2019) and metabolic diseases , providing new insights, and revealing new therapeutic targets and strategies (Yofe et al., 2020) . In the context of infectious diseases, scRNA-seq studies have started to identify the underlying cells and pathways interacting with various pathogens (Drayman et al., 2019; Shnayder et al., 2018; Steuerman et al., 2018; Zanini et al., 2018) . During the immune response to a pathogen, a very limited number of antigen-positive or infected cells initiate and modulate the host immune response (Blecher-Gonen et al., 2019) , while most of the tissue response is propagated through cytokines, such as type I IFN signaling, to bystander, uninfected cells. It is therefore essential to develop new analytical tools to identify the rare infected cells in order to better understand complex hostvirus interactions underlying these pathologies. Multiple experimental tools have been developed over the years to track virus-infected cells in vivo, characterize the cellular state of the infected cells, and differentiate them from their bystander neighbors. These include fluorescently labeled pathogens or pathogens expressing fluorescent proteins (De Baets et al., 2015; Blecher-Gonen et al., 3 2019), as well as reporter mice (Lienenklaus et al., 2009) . However, in the case of human clinical samples, these tools are limited, making the pathogen-infected cells and viral reservoir cell types hard to detect.

Viruses exploit their host cells to first express viral genes, optimize the cellular environment, and then fully activate the viral replication program. As scRNA-seq technologies rely on polyadenylated RNA isolation and amplification, current scRNA-seq methods can, in theory, detect these viral RNA programs and therefore enable accurate identification of the bona fide infected cells and their unique properties at single-cell resolution. While such an approach has already been used to study both in vitro (Drayman et al., 2019; Shnayder et al., 2018) and in vivo infection models (Steuerman et al., 2018) , no general computational framework has been developed to detect viruses and analyze host-viral maps in clinical samples. Here we present a new computational tool, called Viral-Track, that is designed to systematically scan for viral RNA in scRNA-seq data of physiological viral infections using a direct mapping strategy. Viral-Track performs comprehensive mapping of scRNAseq data onto a large database of known viral genomes, providing precise annotation of the cell types associated with viral infections. Integrating these data with the host transcriptome enables transcriptional sorting and differential profiling of the viral-infected compared to bystander cells.

Using a new statistical approach for differential gene expression between infected and bystander cells, we are able to recover virus-induced programs and reveal key host factors required for viral replication. Viral-Track is able to annotate the viral program with high accuracy and sensitivity, as we demonstrate in several in vivo mouse models of infection, as well as human samples of hepatitis B virus (HBV) infection. Applying Viral-Track on Bronchoalveolar Lavage (BAL) samples from moderate and severe COVID-19 patients, we reveal the infection landscape of SARS-CoV-2 and its interaction with the host tissue. Our analysis shows a dramatic impact of the SARS-CoV-2 virus on the immune system of severe patients, including replacement of the tissue resident alveolar macrophages with recruited inflammatory monocytes, neutrophils, and macrophages and an altered CD8 + T cell cytotoxic response, compared to mild cases. We find that the SARS-CoV-2 mainly infects the epithelial and macrophage subsets. In addition, Viral-Track detects an unexpected co-infection of the human Meta-pneumovirus in one of the severe patients. This study establishes ViralTrack as a broadly applicable tool for dissecting mechanisms of viral infections, including identification of the cellular and molecular signatures involved in virus-induced pathologies.

All single cell RNA sequencing (scRNA-seq) computational packages implement a pipeline that initially aligns the sequenced reads to the expressed part of a reference host genome of the relevant organism profiled. Irrelevant reads, representing other organisms, primers, adaptors, template switching oligonucleotides, and other contaminants are then commonly discarded. We reasoned that during infection, and likely many other pathological processes, these reads can potentially carry valuable information about viral RNA that is discarded in this filtering step. In order to efficiently detect viral reads from raw scRNA-seq data in an unsupervised manner, we developed Viral-Track, an R-based computational pipeline ( Figure 1A ; STAR Methods). Briefly, Viral-Track relies on the STAR aligner (Dobin et al., 2013) to map the reads of scRNA-seq data to both the host reference genome and an extensive list of high-quality viral genomes (Stano et al., 2016) . Since viral reads are highly repetitive and generate substantial sequencing artifacts, the viral genomes identified in Viral-Track with a sufficient number of mapped reads are then filtered, based on read mapping quality, nucleotide composition, sequence complexity, and genome coverage, to limit the occurrence of false positives (STAR Methods). Due to the lack of high-quality viral genome annotations, Viral-Track includes a de novo transcriptome assembly on the identified viruses using StringTie (Pertea et al., 2015) . Finally, viral reads are demultiplexed, quantified using Unique Molecular Identifiers (UMI) and assigned to unique viral transcripts and cells (Figure 1A and S1A).

The Viral-Track algorithm has been designed to robustly handle various types of scRNA-seq datasets, as illustrated below, and is publicly accessible at https://github.com/PierreBSC/Viral-Track.

In order to evaluate the specificity and sensitivity of Viral-Track, we benchmarked Viral-Track on several scRNA-seq datasets (Table S1) . These datasets include a large number of experiments we conducted as well as published studies that span several tissues (lung, spleen, liver and lymph node) and a wide range of viruses: Influenza A, Lymphocytic Choriomeningitis Virus (LCMV), Vesicular Stomatitis Virus (VSV), Herpes Simplex Virus 1 (HSV-1), Human Immunodeficiency Virus (HIV), and Hepatitis B Virus (HBV). We first evaluated mouse lungs infected in vivo by Influenza A virus and sequenced using MARS-seq2.0 (Keren-Shaul et al., 2019; Steuerman et al., 2018) . Viral-Track analysis specifically detected the 8 distinct Influenza A viral segments (NC_002016 to NC_002023 Refseq nucleotide sequences) from the specific infecting strain (H1N1 Puerto Rico 8 strain) ( Figure   1B ). We performed transcriptome assembly to test the feasibility of reconstructing the viral transcriptome from 3'-enriched scRNA-seq data. The results were highly coherent with the current knowledge of Influenza A transcriptome, exemplified by Viral-Track's ability to identify docu-5 mented spliced transcript structures with single-nucleotide precision. For instance, we identified the exact location of the key splicing site on segment 7 that gives rise to M2 transcript and links nucleotides 51 and 740 (Dubois et al., 2014) (Figure 1C) . Quantification of the number of viral reads across different experimental conditions was consistent with current knowledge of the disease, with lung stomal cells of non-immune lineages (CD45 -) exhibiting a significantly higher viral load compared to immune cells (CD45 + ) (p = 0.039, two-tailed Welch's t-test) ( Figure 1D ).

As inbred mice lack the Influenza-specific restriction factor Mx1, Influenza A infection is extremely virulent in inbred mice (Haller et al., 1980) . Moreover, all Influenza A mRNA are capped and polyadenylated, making them an optimal substrate for scRNA-seq isolation and amplification protocols.

We therefore evaluated the sensitivity and specificity of Viral-Track in a more challenging dataset.

In this model, photoactivatable-GFP (PA-GFP) mice where infected with LCMV (Armstrong acute strain), a virus lacking strong poly(A) mRNA signals (Burrell et al., 2017) , via injection to the footpad. 72 hours post infection, CD45 + splenic immune cells from different spatial niches; T zone, B zone, Marginal Zone, and total spleen, were profiled using the NICHE-seq technology (Medaglia et al., 2017) . Even though the LCMV viral mRNAs is poorly polyadenylated, we detected mRNA molecules that converted to cDNA through priming of the MARS-seq oligo(dt) RT primer, and Viral-Track successfully identified the two viral segments (LCMV segment L (NC_004291) and S (NC_004294), Figure S1B ), albeit the number of detected reads was an order of magnitude lower than the number observed in Influenza A infection ( Figure 1E) . We detected viral reads in samples from the Marginal zone, B zone and the total spleen, but not in T zone samples, and marginal zone samples exhibited significantly higher viral load compared to B zone and total spleen samples (Figure 1E ; p = 0.0067 and 0.0083 respectively, two-tailed Welch's t-test). This observation is in line with the biology of LCMV, which primarily infects macrophages and lymphocytes from the Marginal Zone of the spleen (Müller et al., 2002) .

We next evaluated whether Viral-Track is sensitive to barcode swapping during Illumina-based scRNA-seq (Griffiths et al., 2018) , which, in the case of viral RNA detection, can lead to the false assignment of viral reads to uninfected cells. To this end, we infected mice with one of two different viruses, LCMV and VSV, and performed MARS-seq2.0 on CD45 + CD19 -CD3non-B/T cells from the auricular draining lymph node one day after infection (STAR Methods). All samples were sequenced concurrently to test for cross-sample viral read contamination. For both viruses, Viral-Track was able to identify the correct viral segments (Figure S1C-D), with no cross-contamination, evident by the absence of VSV reads detected in the LCMV-infected cells and vice versa ( Figure   S1E ). We further generalized Viral-Track for commonly used scRNA-seq technologies and non-6 RNA viruses. We applied Viral-Track to scRNA-seq data from a recently publication of human primary cells infected ex vivo with Herpes Simplex Virus 1 (HSV-1), a linear double stranded DNA virus, generated by the Drop-seq platform (Drayman et al., 2019; Macosko et al., 2015) . We found that Viral-Track detected and identified correctly HSV-1 RNA specifically in the infected samples but not in the controls (NC_001806 Refseq nucleotide sequences, Figure S1F -G). Finally, we analyzed scRNA-seq data of CD4 + T cells infected ex vivo with HIV-1 (Bradley et al., 2018) , generated using the droplet-based chromium platform (Zheng et al., 2017) . Viral-Track successfully identified HIV as the unique virus present in the infected samples ( Figure S1H-I) , but detected significant amounts of HIV-1 viral reads in one control samples probably due to ambient contamination .

We further tested Viral-Track's applicability for detecting viral reads in human clinical samples.

For this purpose, we generated scRNA-seq data from a liver biopsy of an untreated Hepatitis B patient and analyzed the data using Viral-Track. Viral-Track successfully identified the Hepatitis B Virus (HBV) as the only virus present in the sample ( Figure 1F ) with 18420 reads assigned to the HBV genome (NC_003977 Refseq sequence). Coverage analysis revealed a strong peak located at the 5' end of the C gene, encoding for the main core protein, suggesting that the HBV virus is actively producing virions ( Figure 1G ). We then overlaid the viral data on the host transcriptome to identify infected and bystander populations. A total of 13,803 cells passed a lenient quality control, permitting apoptotic signals that may arise from viral infection. We identified several non-immune cell types (Figure S1J Together, this extensive list of validations demonstrate that Viral-Track is a sensitive and accurate method to detect and identify in an unsupervised manner virus strains in diverse scRNA-seq samples, in different tissues, and at varying viral types and loads. Importantly, Viral-Track can be applied to human clinical sample to extract valuable insight into the biology of the host-virus interactions.

To further evaluate the accuracy of Viral-Track against a well-established model for tracking infection in single cells, we infected mice with a GFP-expressing LCMV virus (LCMV-GFP virus) (Medaglia et al., 2017) . We performed MARS-seq on GFP + splenocytes and total spleen cells 72h

post-infection and analyzed the sequenced cells ( Figure S2A -B; STAR Methods). GFP + cells were enriched for vUMI + cells compared to total spleen ( Figure S2A ). We then calculated whether the cells positive for the LCMV-GFP signal (GFP + cells) were similar to the ones designated by Viral-Track as containing viral UMIs (vUMI + ). Following clustering and annotation, we observed similar proportions of GFP + and vUMI + cells across cell clusters (Figure 2A and S2C ; R=0.95, p = 9.0 * 10 -12 ), with monocytes, marginal zone B cells (MZBs) and macrophages being the major infected cell types. We then evaluated the transcriptional signatures within these two sets of cells by computing the Pearson correlation between each pair of cells. We observed similar distribution of Pearson correlation within the GFP + and vUMI + monocyte cells ( Figure 2B ) that was significantly higher (median correlation of 0.65, 0.64 and 0.51, respectively) than the correlation observed between GFP -vUMIbystander monocytes. We conclude that Viral-Track correctly identifies a homogeneous set of infected cells from in vivo scRNA-seq samples similar to the one identified by conventional reporter viruses, even in the more difficult scenario in which viral transcripts are poorly polyadenylated.

We next evaluated the ability of Viral-Track to detect host factors associated with virus replication.

For this purpose, we developed for the Viral-Track pipeline a statistical method that detects differentially expressed genes based on data binarization and complementary log-log regression (Methods and Methods S1). We used this approach to test for transcriptional differences between bystander and infected cells during spleen LCMV infection across the three main infected cell types:

macrophages, MZB cells and monocytes. We observed that MZB cells were the most influenced by the viral infection, compared to monocytes and macrophages (107, 42 and 3 genes up-regulated respectively, Z-score > 3) ( Figure 2C ). We performed Gene Ontology enrichment analysis on the up-8 regulated genes in MZB cells, and observed a significant enrichment in several pathways, including 'Chromosome Organization', 'DNA replication' and 'Cell Cycle', suggesting that LCMV triggers cell division in MZB cells ( Figure 2D) . Indeed, LCMV-infected MZB cells exhibited higher levels of cell cycle related genes such as Smc2 (required for chromatin condensation), Cdc6 (regulator of DNA replication) and Stm1 (regulator of mitotic spindle) ( Figure 2E, S2D) , but also of Fibrillarin (Fbl), a host factor whose expression is required by several viruses (Deffrasnes et al., 2016 ) ( Figure   2E ) . This is in line with a previous report highlighting the ability of LCMV to trigger an abortive form of cell division blocked in the G1 phase (Beier et al., 2015) . Altogether, our results show that Viral-Track is sufficient to detect infected cells in in vivo scRNA-seq data and infer the differential gene expression in infected versus bystander cells.

COVID-19 is a viral disease caused by SARS-CoV-2 infection, which has recently been recognized as the cause for a pandemic (Wang et al., 2020a) . Little is currently known about the course of the disease and how the virus interacts with the host immune system in its mild and severe manifestations. To gain insights on the infection course in humans, we performed scRNA-seq and Viral-Track analysis on BALF samples from three mild and six severe COVID-19 patients (Liao et al., 2020) . In total, 50,615 cells passed QC and were analyzed using the MetaCell algorithm ( Figure S3D ). These results were robust across different analysis platforms (Liao et al., 2020) .

Comparison of the cellular landscape of mild and severe patients revealed key differences in the composition of BAL samples ( Figure 3B -C). We found changes to each of the three compartments 9 (Figures 3D-F and S3E-G). While alveolar macrophages and pDC where enriched in the myeloid compartment in the mild patients, the severe patients' myeloid cells were characterized by a patientspecific diversity associated with accumulation of neutrophils, FCN1 + monocytes and monocytederived SPP1+ macrophages ( Figure 3D, S3E) . Additionally, NK cells and naïve CCR7 + CD4 + T cells were consistently enriched across severe patients BAL, while activated ZNF683 hi CD8 + cytotoxic T cells were specific to mild patients ( Figure 3E, S3F) . We also observed changes in the epithelial compartment, as severe patients exhibited higher numbers of club cells and AT2 cells (Figure 3F and S3G). Investigating expression patterns of shared gene expression programs, we observed that NK cells and the CD4 + Tfh cells are the most proliferative compartments (Figure 3G ), while a broad Interferon type I response, a hallmark of viral response, is mainly expressed by neutrophils and, to a lesser extent, FCN1 + monocytes ( Figure 3H ). We next performed in-depth differential gene expression analysis between subsets characteristic of mild or severe patients. We found that CD4 + T cells in the severe patients exhibit a more naïve phenotype, expressing higher levels of IL7R, CCR7, S1PR1 and LTB. The activated CD8 + T cells signatures are restricted to the mild patients, and have higher levels of the effector molecules XCL1, ITGAE, CXCR6 and ZNF683 ( Figure 3J ). Together, we identified dramatic differences between the mild and severe COVID-19 patients, including an inflammatory signature and a perturbed immune response associated with the severe manifestation of the COVID-19 disease.

These also highlight potential immunotherapy treatment of the severe patients by targeting the hyper inflammatory response that is activated by inflammatory cytokines such as IL-6 and IL-8 (Liu et al., 2019) ( Figure S3H ).

To characterize the in vivo crosstalk of SARS-CoV-2 with its human host, we applied Viral-Track on the data generated from the nine SARS-CoV-2 patients and the rich cellular landscape we identified. SARS-CoV-2 transcripts were detected in all six severe samples in variable amounts, ranging from less than 400 transcripts to more than 15,000 ( Figure 4A, S4A) . In contrast, no viral read was detected in the three mild patients ( Figure 4A ). Coverage analysis revealed that the majority of the viral reads mapped to the 3' end of the viral segment and corresponded to positive stranded RNA ( Figure 4B ). This is in agreement with the coronavirus transcription: due to a nested transcription process all genomic and subgenomic RNA molecules share the same 3' end (Masters, 2006) . We then analyzed the enrichment of vUMIs in the cell populations represented in the BAL samples. We observed a strong enrichment of viral reads in the ciliated and epithelial progenitor population, two known cellular targets of the virus, which express the main receptor of the SARS-CoV-2 virus ACE2, as well as TMPRSS2, a protease essential for SARS-CoV-2 entry ( Figure 4C , S4B, Table   S2 ) (Hoffmann et al., 2020) . We also observed enrichment of SARS-CoV-2 reads in the SPP1 + macrophage population, suggesting that SARS-CoV-2 can infect immune cells from the myeloid compartment or that SPP1 + macrophages phagocytose viral infected cells or particles. Differential gene expression analysis between vUMI + infected and vUMIbystander SPP1 + macrophages in the patients with the highest viral load, revealed that infected macrophages have higher expression of chemokines (CCL7, CCL8, CCL18) and APOE, and lower expression of TAOK1, a serine/threonine-protein kinase in the p38 MAPK cascade ( Figure S4C ). Interestingly, CD147 (also known as BSG) a potential new receptor (Wang et al., 2020b) is expressed by all cell types, including immune cells, suggesting alternative routes for the virus to infect these cells.

Often in cases of infectious diseases, the specific infecting virus is not known, or may be accompanied by co-infection with additional unknown viruses. Viral-Track applies an unsupervised mapping strategy, and is optimally designed to systematically profile the source of infection or coinfections in human clinical samples. To our surprise, Viral-Track analysis of data from one of the severe patients (S1) revealed the presence of a second virus, the human Metapneumovirus (hMPV) (NC_039199 Refseq sequence, Figure 4D ) with more than one million reads mapped to hMPV in this specific patient. HMPV is a non-segmented, single-stranded and negative-sense RNA virus that is responsible for upper and lower respiratory tract infections in mostly young (<5 years) children, but can also target elderly as well as immuno-compromised patients (Panda et al., 2014) . HMPV has been implicated as a possible source of co-infection with the original SARS-CoV virus (Chan et al., 2003) .

Coverage analysis revealed that most reads fall into the N, P, M, F, M2, SH, G but not L genes of hMPV ( Figure 4E ). We observed a typical pattern of biased scRNA-seq coverage, indicating that the N, P, M, F, M2, SH and G genes are actively transcribed, and suggesting that the hMPV was active and replicating at the time of sample collection. Analysis of the viral UMI distribution across cells revealed substantial viral load in a large subset of the cells, spanning hundreds to thousands vUMIs per infected cell (Figure 4F) , independently of the total host UMIs in that cell ( Figure   S4D ). We mapped the infected cells and characterized their distribution across cell types. The in-fected patient is characterized by high levels of monocytes and CD4 + T cells ( Figure S4E ). Unlike the SARS-CoV-2 virus infection map, HMPV infected cells were highly enriched in the monocyte compartment but not in the epithelial and SPP1 + macrophage compartments ( Figure 4G ).

We tested whether the hMPV could alter the function of the infected monocytes, and therefore influence the course of the disease. Using Viral-Track, we detected a large number of up-and downregulated genes in infected monocytes compared to bystander monocytes ( Figure 4H ). Interestingly, several key receptor genes required for monocyte activation such as CD16 (FCGR3B), G-CSF receptor (CSF3R) and the formyl peptide receptor (FRP1) were down-regulated in the infected compared to the bystander cells. Moreover, we observed a dramatic down-regulation of Type I Interferon signaling and interferon stimulated genes (ISGs), including viral restriction factors, (e.g.

IFIT3). A gene set enrichment analysis ( Figure S4F ) revealed a strong enrichment of interferon response genes in the down-regulated gene set, suggesting that the hMPV is strongly down-regulating the IFN response pathway. Several anti-inflammatory genes were up-regulated, including LILRB4

(a potent inhibitor of monocyte activation (Lu et al., 2009) ) and MITF, a transcription factor known to be a critical suppressor of innate immunity (Harris et al., 2018) . Lastly, we observed a positive and significant association between total number of hMPV UMIs and production of type I IFN,

highlighting that while hMPV dampens the response to type I IFN, production of this signal is highly restricted to a rare (~1%) population of cells with a high viral load ( Figure S4G) . Altogether, our analysis described the distribution of SARS-CoV-2 infected cells in patients BAL, and revealed the presence of a viral co-infection by the hMPV that dampens the immune activation of the monocyte compartment in this patient. Further large-scale analysis of mild versus severe patients' needs to be conducted to better understand if the co-infection is correlated or even causative in SARS-CoV-2 pathology.

The virosphere contains hundreds of thousands of species that constantly interact with their host cells. Over the years, several genomic techniques have been developed to detect virus-derived sequences in human samples. For instance, deep sequencing assays are unbiased and sensitive in their ability to detect extremely rare viral sequences (Moustafa et al., 2017) , but do not provide information about the infected cells and the cellular changes induced by the infection. Alternatively, it is possible to combine DNA probes with scRNA-seq to enrich for viral sequences and increase the sensitivity of the assay, but this requires prior knowledge of the viruses present in each sample (Zanini et al., 2018) . Here we present Viral-Track, a robust and unsupervised computational pipe-line that can detect viral RNA in any scRNA-seq dataset without the need for experimental modifications or prior knowledge of the infecting agent. Viral-Track was benchmarked on data originating from various tissues, infected by viruses with marked differences in their RNA properties, and generated with different scRNA-seq platforms. We demonstrate that Viral-Track can readily provide essential information on infection status in clinical samples, identify infected cells, probe viralinduced transcriptional alterations, and reveal cases of coinfection.

In practice, only 70-85% of scRNA-seq reads map to the host genome, and represent polyadenylated exonic host transcripts, whereas the remainder of the data is usually overlooked in analysis. We

show that these unmapped scRNA-seq reads, in pathological human samples, potentially contain valuable information on viral infection, and can be effectively used for viral genome assembly. Viral-Track can resolve complex cellular ecosystems perturbed by viral infection, and provide an unbiased map of the infected cells, as well as the transcriptional perturbations induced by the virus at the single cell level. We combine Viral-Track with a novel statistical approach to detect differentially expressed genes from scRNA-seq data, therefore allowing to detect gene expression changes triggered by viral infection and differentiate them from the more abundant bystander effects, such as type I IFN signaling, at the single cell level. Further advances will focus on applying Viral-Track on largescale datasets containing scRNA-seq data from dozens of samples, leading to robust singlecell viral metagenomic studies that characterize the viral evolution and interactions of virus-induced disease mechanisms with host genetics.

Here we applied scRNA-seq and Viral-Track analysis to COVID-19 patient-derived samples to provide a cellular and viral atlas of the BAL lung cells from COVID-19 patients. This analysis revealed the diversity of the immune responses across COVID-19 patients and between mild and severe patients. We expect that as the pandemic keeps spreading and global research efforts grow, additional scRNA-seq samples from COVID-19 patients will be generated, including patients treated with emerging immunotherapies . Such an approach might help to solve key questions including the contribution of the humoral response (Iwasaki and Yang, 2020) , the role of the IL6 pathway (Herold et al., 2020) , and the immune memory induced by the virus (Prompetchara et al., 2020) . Viral-Track can contribute to the global effort to identify the different cellular compartments that are targeted and affected by COVID-19 and other viruses, and to detect possible coinfection by unexpected viruses. Coinfections are gaining recognition in the scientific and medical community as critical factors in disease prognosis . So far, research focused mainly on coinfections of bacterial sources, or of well-known viruses such as Influenza A . Understanding the diversity of viral co-infections and their mechanisms of immune suppres-13 sion at the cellular and molecular level could therefore provide highly valuable information and lead toward possible therapeutic targets, especially for severe patients, whose treatment options are limited. 

The authors declare no conflict of interest. lymphoid (E), and epithelial (F) compartments, across the nine patients. Diamond marks patient S1, co-infected with the human Metapneumovirus (Figure 4D-H) . G. Percentage of proliferating cells (determined by thresholding over a cell cycle related gene module, detailed in Table S3) 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Ido Amit (ido.amit@weizmann.ac.il).

This study did not generate new unique reagents.

The whole Viral-Track pipeline is freely available at https://github.com/PierreBSC/Viral-Track.

The datasets generated during this study were deposited to the Gene Expression Omnibus (GEO) repository with accession codes: GSE145926, GSE149443.

Mice C57BL/6 mice were purchased from Jackson Laboratories and bred and housed at the Weizmann Institute of Science animal facility, under specific pathogen-free conditions. Female mice, 6-8 weeks of age, were used for all experiments. Experimental protocols were approved by the Weizmann Institute of Science Ethics Committee and were performed according to institutional guidelines. (Jaitin et al., 2014) . Four empty wells were kept in each 384-well plate as a no-cell control for data analysis. Immediately after sorting, each plate was spun down to ensure cell immersion into the lysis solution, snap frozen on dry ice, and stored at -80C until processing Single-cell RNA-seq libraries were prepared as previously described (Jaitin et al., 2014) . In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously (Jaitin et al., 2014) .

Full description of the protocol used to generate the Influenza A lung data can be found in (Steuerman et al., 2018) . Influenza PR8 H1N1 influenza virus (A/Puerto Rico/8/34) was cultivated in hen egg anion. 40µL of diluted virus (6x10 3 PFU per mouse) were inoculated intranasaly to the mice, or 40µL of PBS for the control mice. Mice were killed 48 or 72h post infection and the lung perfused. Immune and none-immune cells were then extracted using two different extraction protocols before being single-cell sorted in 384-well plates and sequenced using the original MARS-seq protocol (Jaitin et al., 2014) .

20 Description for the full protocol used to generate the NICHE-Seq spleen data can be found in (Medaglia et al., 2017) . Briefly female mice received 1x10 6 FFU of LCMV-Arm or LCMV-Arm-eGFP in the footpad. 72 hours after injection, spleens were harvested and forced through a 70µm mesh to form a single-cell suspension. Cells were then single-cell sorted using a SORP-aria into 384-well plates containing lysis buffer before processing the plate according to the MARS-seq protocol (Jaitin et al., 2014) . All infectious work was performed in designated Biosafety Level 2 (BSL-2) and BSL-3 workspaces in accordance with institutional guidelines

The approximately 1 cm long Liver biopsy was homogenized by mincing with scissors into smaller pieces (~0.5 mm2 per piece). Then the tissue was transferred into 10 ml of enzyme mix consisting of 0.3 mg/ml collagenase type IV (Sigma, C9891) and DNase I (Sigma, D5025) for mild enzymatic digestion for 1 h at 37 °C while shaking. 5 ml of Dulbecco's phosphate-buffered saline (DPBS, Thermo, 14190250) supplemented with 5% FBS was added to interrupt digestion and dissociated cells in suspension were passed through a 40 µm strainer and centrifuged at 300g for 5 min at 4 °C.

Erythrocytes were lysed using Ammonium-Chloride-Potassium (ACK, Thermo, A1049201), and finally cells were re-suspended in DPBS supplemented with 1% FBS at the concentration of 2, 000 cells/µl for scRNA-Seq. The single-cell capturing and downstream library constructions were performed using the Chromium Single Cell 3' V3 library preparation kit according to the manufacturer's protocol (10x Genomics). Full-length cDNA along with cell-barcode identifiers were PCRamplified and sequencing libraries were prepared and normalized to 3 nM. The constructed library was sequenced on BGI MGISEQ-2000 platform. The Cell Ranger Software Suite (Version 3.1.0) was then used to perform sample de-multiplexing, barcode processing and single-cell 3' UMI counting with human GRCh38 as the reference genome 10X COVID-19 data generation 20 ml of BALF was obtained and placed on ice. BALF was processed within 2 hours and all operations were performed in BSL-3 laboratory. By passing BALF through a 100 µm nylon cell strainer to filter out lumps, the supernatant was centrifuged and the cells were re-suspended in the cooled RPMI 1640 complete medium. Then the cells were counted in 0.4% trypan blued, centrifuged and re-suspended at the concentration of 2 × 10 6 /ml for further use. Total 11 µl of single cell suspension and 40 µl barcoded Gel Beads were loaded to Chromium Chip A to generate single-cell gel bead-inemulsion (GEM). The poly-adenylated transcripts were reverse-transcribed later. The single-cell 21 capturing and downstream library constructions were performed using the Chromium Single Cell 5' library preparation kit according to the manufacturer's protocol (10x Genomics). Full-length cDNA along with cell-barcode identifiers were PCR-amplified and sequencing libraries were prepared and normalized to 3 nM. The constructed library was sequenced on BGI MGISEQ-2000 platform. Each sample was sequenced on a different sequencing run to avoid contamination between samples. The Cell Ranger Software Suite (Version 3.1.0) was then used to perform sample de-multiplexing, barcode processing and single-cell 5' UMI counting with human GRCh38 as the reference genome. A more extensive description of the data generation process can be found in (Liao et al., 2020) .

Reads were aligned using STAR 2.7.0 (Dobin et al., 2013) in the two-pass mode using the following parameters : --runThreadN was set to 14, --outSAMattributes to 'NH HI AS nM NM XS', --outSAMtype to 'BAM SortedByCoordinate', --outFilterScoreMinOverLread to 0.6, --outFilterMatchNminPverLread to 0.6, and --twopassMode to 'Basic'.

As STAR performance drastically dropped when the reference index contains more than 10.000 scaffold/chromosomes, we decided to base our analysis on the limited, but high-quality, viruSITE database (Stano et al., 2016) , derived from the NCBI Refseq database. 

We empirically observed that viral genome sequences can contain highly repetitive subsequences and can therefore create false positive signal. Moreover, some viral genes can share a significant similarity with host genes and also generate mapping artifacts. To remove those, we implemented a strict filtering approach where for each viral segment, a list of mapping features are measured and used to estimate the quality of the mapping.

Following the alignment, the resulting BAM files were processed using the samtools toolbox (Li et al., 2009) : first the BAM files were indexed using the samtools index command. Virus segment with more than 50 mapped reads were detected using the samtools idxstats command and a unique bam file was then created for each of the viral segment using the samtools view command.

Each viral bam files were then loaded into an R environment using the readGAlignments() function from the GenomicAlignments package. Various features were then extracted to assess the quality of the mapping:

-The length of the longest mapped contig computed using the coverage() function.

-The percentage of the viral segment that is mapped, also computed using the coverage() function.

-The mean sequencing quality of the mapped reads.

-The number and percentage of uniquely mapped reads.

-The mean sequenced entropy of the mapped reads defined as follows: for each mapped read each nucleotide frequency was extracted using the alphabetFrequency() function of the Biostring package and averaged over the reads. Then the corresponding Shanon entropy was computed using napierian logarithm.

Empirically we determined that a mean sequence entropy bigger than 1.2, a coverage bigger than 5% and the longest contig bigger than three times the mean read length is sufficient to consider a viral segment to be present. This filter configuration eliminated all manually identified artifacts in the various benchmarked datasets and was used unchanged in the HBV and COVID-19 patient data analysis.

When using this strategy, we observed two different kinds of 'contamination':

the first one consists of the detection of retroviruses specific to the sequenced host species: this is likely due to the expression of host endogenous retro-viral elements that highly similar to 'real'

retroviruses.

the second is the presence of a plant virus, the Tomato brown rugose fruit virus : this is an emerging virus that infects tomatoes and peppers and is endemic in Israel and Jordan. It is highly contagious and spreads easily. We detected this virus only in samples sequenced in Rehovot (Israel) suggesting that it was due to an airborne contamination.

To improve computation speed, this step was parallelised using the doParallel R package.

As viral genomes are poorly annotated, we decided to systemically reconstruct the transcriptome of each viral segment detected using the transcript assembler StringTie (Pertea et al., 2015) . StringTie was used with default parameter except the minimum isoform abundance parameter -f which was set to 0.01 to detect lowly abundant transcripts and the minimal distance between two transcript -g set to 5.

In order to have a UMI-counting procedure adapted to viral genomes, i.e that distinguish spliced and un-spliced RNA molecule, we developed an in-house R script based on the GenomicRanges, GenomicAlignments and GenomicFeatures packages that used the same strategy as the commercial CellRanger toolkit. Briefly cell barcodes were extracted and compared with a cell barcode whitelist provided by the MARS-seq2 demultiplexing pipeline (Keren-Shaul et al., 2019) : cell barcode that belong to the whitelist were kept while cell barcodes that did not belong to the whitelist but that has a highly similar barcode (Hamming distance equal to one, computed using the stringdist() function from the stringdist package) were corrected and kept. UMIs were also extracted and mono-nucleotide UMIs filtered out. Hamming distances between UMIs assigned to the same cell and the same gene were then computed similarly to cell barcodes and UMIs with a Hamming distance equal to one were aggregated and considered as redundant UMIs. Lastly the mapping file was loaded using the readGAlignments() function from the GenomicAlignments package and reads were assigned to a specific viral gene using the findOverlaps() function from the same package. In case the read mapped to a given viral transcript but was not assigned to any viral gene, it was considered as coming from an un-spliced viral RNA molecule.

Fastq files were downloaded through the SRA Explorer tool (https://ewels.github.io/sra-explorer/#).

Identification and correction of cellular barcode, as well as UMI demultiplexing was performed using UMI-tools 1.0.0 (Smith et al., 2017) . First, cell barcodes were extracted and a putative whitelist computed using the umi_tools whitelist command with the parameters '--stdin -bc-pattern=CCCCCCCCCCCCCCCCNNNNNNNNNN --log2stderr ' for the 10X data. For Drop-Seq data the same command is used except the --bc-pattern option set to 24 CCCCCCCCCCCCNNNNNNNN. Collapsing of the UMIs is performed using the command umi_tools extract with parameters '-bc-pattern=CCCCCCCCCCCCCCCCNNNNNNNNNNstdin -filter-cell-barcode' on the 10X data and with the same command for Drop-seq data except for the --bc-pattern option set to 'CCCCCCCCCCCCNNNNNNNN'. Following the mapping of the reads to viral genomes and transcript assembly, the mapped reads were assigned to transcripts using the R package Rsubread through the function featureCounts() with default parameters. The command umi_tools count is then used to compute the final expression table with the following parameters : --per-gene --gene-tag=XT --assigned-status-tag=XS --per-cell.

High-level analysis were performed using the R-based Pagoda2 pipeline (https://github.com/hmsdbmi/pagoda2/, (Lake et al., 2018) in addition to an in-house R script. Briefly UMI table were loaded and cells with less than 350 UMIs were removed. Lowly abundant genes (less than 100 UMIs)

were also removed from analysis. Analysis of the filtered dataset was then performed similarly to our previous paper ( 

High-level analysis were performed using the R-based Pagoda2 pipeline (https://github.com/hmsdbmi/pagoda2/, (Lake et al., 2018) in addition to an in-house R script. Briefly UMI table were loaded and cells with less than 1000 UMIs were removed. Lowly abundant genes (less than 50 UMIs)

were also removed from analysis. Analysis of the filtered dataset was then performed similarly to our previous paper (Blecher-Gonen et al., 2019) by using the 1000 most variant genes and 100 PCs for dimensionality reduction. kNN graph was build with a parameter K equal to 30 and Louvain's method used for clustering. Cluster marker genes were computed by using the getdiffGenes function with default parameters. Data were visualized using UMAP (McInnes et al., 2018) implemented by the uwot package.

Upstream processing of reads was done with the CellRanger toolkit, resulting in a UMI table of 75,790 cells with a median UMI count of 2,442, and a median of 868 genes per cell. Cells with less than 500 UMI, or more than 50% mitochondrial genes were excluded.

We used the MetaCell package (Baran et al., 2019) to group single cells from all patients into groups of transcriptionally homogeneous groups, termed metacells . We first removed mitochondrial genes, ERCC, and the diverse immunoglobulin genes (IGH, IGK, and IGL).

Gene features for metacell covers were selected using the parameter Tvm=0.4, total umi > 30, and more than 4 UMI in at least 3 cells (using the functions mcell_gset_filter_varmean, and mcell_gset_filter_cov). We excluded gene features associated with the cell cycle, stress response, type I interferon, and batch-specific genes via a clustering approach ( . We then hierarchically clustered the correlation matrix between these genes (filtering genes with low coverage and computing correlation using a down-sampled UMI matrix) and selected the gene clusters that contained the above anchor genes. We thus retained 402 genes as features (Table S3) . We used metacell to build a kNN graph, perform boot-strapped co-clustering (500 iterations; resampling 70% of the cells in each iteration), and derive a cover of the co-clustering kNN graph (K=100). Outlier cells featuring gene expresssion higher than 4-fold than the geometric mean in the metacells in at least one gene were discarded.

Annotation of the metacell model was done using the metacell confusion matrix and analysis of marker genes. Detailed annotation within the myeloid, lymphoid and epithelial compartments was performed using hierarchical clustering of the metacell confusion matrix ( Figure S3A ) and supervised analysis of enriched genes. Metacells enriched for markers from more than one lineage (either T (TRBC2), myeloid (S100A8, C1QB), epithel (KRT18), and plasma cells (XBP1)) were marked as doublets and discarded from further analysis. We additionally discarded metacells of erythrocytes or plasma cells from further analysis.

To derive cell cycle and type I interferon response co-expressed gene modules, we used a clustering-approach as described in the previous paragraphs (using the functions mcell_mat_rpt_cor_anchors and mcell_gset_split_by_dsmat) on a set of cell cycle and interferon genes. We clustered, and manually inspected the resulting clusters, retrieving 72 cell-cycle related and 65 interferon related genes (Table S3) .

To extract proportion of proliferating cells (Figure 3G) , we calculated for each cells the number of cell-cycle related transcripts per 1,000 UMI. Cells with more than 8 transcripts were determined proliferating.

To test for SARS-CoV-2 infection specificity in different cell populations, we computed for each metacell the total number of host UMIs (hUMI) and viral UMIs (vUMI) in the three severe patients (S1-3). We then computed for each metacell its expected vUMI cout, based on its total UMI count (hUMI + vUMI) and the total vUMI proportion across all cells. Figure 4C shows log 2 fold change between the observed and expected UMI in each metacell, after adding a regularization factor (=5)

for each factor. Log 2 fold change for the 27 subsets in Figure 3A , and calculated for each severe patient separately is shown in Table S2 .

Testing for hMPV infection specificity was done in a similar manner. However, since UMI distribution across cells was abundant and heavy-tailed, we computed for each metacell the expected number of vUMI + cells instead of its total vUMI count. A cell was determined vUMI+ if it had more than 10 viral UMI, as determined by automatic thresholding ( Figure 4F ). Figure 4G shows log 2 fold change between the observed and expected vUMI+ cells in each metacell, after adding a regularization factor (=5) for each factor.

ScRNA-seq data are intrinsically noisy data with a large proportion of zeros values (previously called dropouts) due to limited sampling of the initial mRNA molecule pool. In addition, cell library size is a major cofounder variable, even after common normalization procedures such as TPM, especially for lowly expressed genes (Hafemeister and Satija, 2019) . We therefore improved the method used in our former paper (Blecher-Gonen et al., 2019) that was based on logistic regression.

Briefly our method is based on the global trend of the field that consists in sequencing large amounts of cells but with a limited sequencing depth. Such approach will produce mostly 'binary' data and seem to be represent the best compromise on a cost/efficiency point of view (Svensson et al., 2019) . So far, several statistical models have been used to model and analyze scRNA-seq count data, most of them being based on the zero-inflated negative-binomial (ZINB) distribution (Finak et al., 2015; Kharchenko et al., 2014) . However, recent studies suggested that those models are too complex and introduce artificial complexity (Silverman et al., 2018; Svensson, 2020; Townes et al., 27 2019) . We hypothesize that with such binary data, current models will not fit properly and more suited ones need to be developed.

We therefore developed a new approach based on the binomial complementary Log-log regression (cloglog model): once a given group of cells has been isolated, through Louvain's clustering for instance (Blondel et al., 2008) , we first dichotomized gene expression (if the normalized expression is bigger than 0 the gene is considered as expressed) and then computed a binomial Generalized Linear Model (GLM) with a complementary log log link function (cloglog) using the glm() R function.

To mitigate the variation of the library size as well as the global effect of the infection (bystander effect), we include both variables in the regression model. The corresponding p-value are then computed using a Likelihood Ratio Test (LRT) and then corrected using Benjamini Hochberg correction (Benjamini and Hochberg, 1995) .

For a more comprehensive description of the approach please see Methods S1.

In the case of the HBV and hMPV infections, we observed that cells could contain from one to several thousands UMIs. In order to know which cells were really infected and which one contain viral UMIs due to ambient contamination, we decided to apply Otsu's thresholding after logarithmic transformation. Otsu's method was implemented using an in-house R script (Otsu, 1979) .

Gene set enrichment analysis was performed using the online GSEA tool https://www.gseamsigdb.org/gsea/index.jsp (Liberzon et al., 2015; Subramanian et al., 2005) . The enrichment analysis was performed using the Hallmark and Gene Ontology biological process databases. False detection rate was set to 0.05. Only the top 10 most enriched terms were reported. Methods S1. scRNA-seq differential expression analysis using cloglog regression. Related to Fig 

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions

Novel mechanism of arenavirus-induced liver pathology

Controlling the false discovery rate: a practical and powerful approach to multiple testing

Single-Cell Analysis of Diverse Pathogen Responses Defines a Molecular Roadmap for Generating Antigen-Specific Immunity

Fast unfolding of communities in large networks

Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency

Fenner and White's medical virology (Amsterdam

Advancing an HIV vaccine; advancing vaccinology

Human metapneumovirus detection in patients with severe acute respiratory syndrome

A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)

STAR: ultrafast universal RNA-seq aligner

HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations

Influenza viruses and mRNA splicing: doing more with less

Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

Detection and removal of barcode swapping in single-cell RNA-seq data

Normalization and variance stabilization of single-cell RNAseq data using regularized negative binomial regression

Host gene influences sensitivity to interferon action selectively for influenza virus

A direct link between MITF, innate immunity, and hair graying

Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs

Temporal dynamics in viral shedding and transmissibility of COVID-19

Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients

SARS-CoV-2 Cell Entry Depends on ACE2 30 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer's Disease. Front. Aging Neurosci

The potential danger of suboptimal antibody responses in COVID-19

Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types

Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner

A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease

MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with singlecell RNA sequencing

Bayesian approach to single-cell differential expression analysis

Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain

The Sequence Alignment/Map format and SAMtools

Dysfunctional CD8 T Cells Form a Proliferative

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing tle

The Molecular Signatures Database Hallmark Gene Set Collection

Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN-β In Vivo

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

Leukocyte Iglike Receptor B4 (LILRB4) Is a Potent Inhibitor of FcγRI-mediated Monocyte Activation via Dephosphorylation of Multiple Kinases

Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets

The molecular biology of coronaviruses

Umap: Uniform manifold approximation and projection for dimension reduction

Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science (80-. )

The blood DNA virome in 8,000 humans

Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production

Antiviral immune responses: triggers of or triggered by autoimmunity?

A Threshold Selection Method from Gray-Level Histograms

Human metapneumovirus: review of an important respiratory pathogen

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

The emergence of Zika virus and its new clinical syndromes

Immune responses in COVID-19 and potential 32 vaccines: Lessons learned from SARS and MERS epidemic

Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing

Naught all zeros in sequence count data are the same

UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy

viruSITE-integrated database for viral genomics

Databases Curation

Dissection of Influenza Infection In Vivo by Single-Cell RNA Sequencing

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Droplet scRNA-seq is not zero-inflated

Quantifying the tradeoff between sequencing depth and cell number in single-cell RNA-seq

Feature selection and dimension reduction for single-cell RNA-Seq based on a multinomial model

A novel coronavirus outbreak of global health concern

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia

Decontamination of ambient RNA in single-cell RNA-seq with DecontX

Single-cell genomic approaches for developing the next 33 generation of immunotherapies

Epstein-Barr virus: 40 years on

Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue

Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

Potential Factors for Prediction of Disease Severity of COVID-19 Patients

Massively parallel digital transcriptional profiling of single cells

A Novel Coronavirus from Patients with Pneumonia in China

Viral-track: a computational framework to analyze host-viral infection maps Viral-track sorts infected from bystander cells and reveals virus-induced expression SARS-CoV-2 infects epithelial cells and alters immune landscape in severe patients Coinfection of SARS-Cov-2 and hMPV affects monocytes and dampen interferon response A computational framework that allows for the identification and characterizaton of virusinfected cells as well as bystander cell responses reveals how SARS-CoV-2 alters the immune responses of patients